These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 21080871)
1. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression. Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871 [TBL] [Abstract][Full Text] [Related]
2. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297 [TBL] [Abstract][Full Text] [Related]
3. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Miyahara M; Tanuma J; Sugihara K; Semba I Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor. Yuanming L; Feng G; Lei T; Ying W Arch Med Res; 2007 Jan; 38(1):106-12. PubMed ID: 17174733 [TBL] [Abstract][Full Text] [Related]
5. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients. Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190 [TBL] [Abstract][Full Text] [Related]
6. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases. Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411 [TBL] [Abstract][Full Text] [Related]
7. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer. Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-IIa squamous cell cervical cancer. Xiong Y; Cao LP; Rao HL; Cai MY; Liang LZ; Liu JH Cell Tissue Res; 2012 Jun; 348(3):515-22. PubMed ID: 22492093 [TBL] [Abstract][Full Text] [Related]
9. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker. Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000 [TBL] [Abstract][Full Text] [Related]
10. High lymph vessel density and expression of lymphatic growth factors in peritoneal endometriosis. Reichelt U; Keichel S; Barcena de Arellano ML; Chiantera V; Schneider A; Mechsner S Reprod Sci; 2012 Aug; 19(8):876-82. PubMed ID: 22539358 [TBL] [Abstract][Full Text] [Related]
11. Does a growing tumour volume induce lymphangiogenesis? A study of oral/oropharyngeal cancer. Chung EJ; Rho YS; Baek SK; Woo JS; Kwon SY; Lee NJ; Chae YS; Jung KY J Otolaryngol Head Neck Surg; 2011 Aug; 40(4):311-7. PubMed ID: 21777549 [TBL] [Abstract][Full Text] [Related]
12. [Association between lymphangiogenesis and clinicopathological features and prognosis in laryngeal carcinoma]. Zou JD; Fu HY; Xu W; Lü ZH; Cao HY; Luan XY Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):461-4. PubMed ID: 21875489 [TBL] [Abstract][Full Text] [Related]
13. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value. Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575 [TBL] [Abstract][Full Text] [Related]
14. Lymphatic vessel density as a prognostic marker in clinical stage I endocervical adenocarcinoma. Saad RS; Ismiil N; Ghorab Z; Nofech-Mozes S; Dubé V; Covens A; Khalifa MA Int J Gynecol Pathol; 2010 Jul; 29(4):386-93. PubMed ID: 20567154 [TBL] [Abstract][Full Text] [Related]
15. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis. Sipos B; Kojima M; Tiemann K; Klapper W; Kruse ML; Kalthoff H; Schniewind B; Tepel J; Weich H; Kerjaschki D; Klöppel G J Pathol; 2005 Nov; 207(3):301-12. PubMed ID: 16161179 [TBL] [Abstract][Full Text] [Related]
16. Lymphangiogenesis in deep infiltrating endometriosis. Keichel S; Barcena de Arellano ML; Reichelt U; Riedlinger WF; Schneider A; Köhler C; Mechsner S Hum Reprod; 2011 Oct; 26(10):2713-20. PubMed ID: 21791438 [TBL] [Abstract][Full Text] [Related]
17. VEGF-C is associated with lymphatic status and invasion in oral cancer. Siriwardena BS; Kudo Y; Ogawa I; Udagama MN; Tilakaratne WM; Takata T J Clin Pathol; 2008 Jan; 61(1):103-8. PubMed ID: 17351086 [TBL] [Abstract][Full Text] [Related]
18. Lymphatic vessel density as a prognostic indicator for patients with stage I cervical carcinoma. Gao P; Zhou GY; Yin G; Liu Y; Liu ZY; Zhang J; Hao CY Hum Pathol; 2006 Jun; 37(6):719-25. PubMed ID: 16733213 [TBL] [Abstract][Full Text] [Related]
19. High lymphatic vessel density correlates with overexpression of VEGF-C in gastric cancer. Hachisuka T; Narikiyo M; Yamada Y; Ishikawa H; Ueno M; Uchida H; Yoriki R; Ohigashi Y; Miki K; Tamaki H; Mizuno T; Nakajima Y Oncol Rep; 2005 Apr; 13(4):733-7. PubMed ID: 15756450 [TBL] [Abstract][Full Text] [Related]
20. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]